cAMP Stimulates SLC26A3 Activity in Human Colon by a CFTR-Dependent Mechanism That Does Not Require CFTR Activity.


Journal

Cellular and molecular gastroenterology and hepatology
ISSN: 2352-345X
Titre abrégé: Cell Mol Gastroenterol Hepatol
Pays: United States
ID NLM: 101648302

Informations de publication

Date de publication:
2019
Historique:
received: 20 08 2018
revised: 07 01 2019
accepted: 07 01 2019
pubmed: 20 1 2019
medline: 5 6 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

SLC26A3 (DRA) is an electroneutral Cl This study re-evaluated cAMP regulation of DRA using new tools, including a successful knockout cell model, a specific DRA inhibitor (DRA DRA is an apical protein in human proximal colon, differentiated colonoid monolayers, and Caco-2 cells. It is glycosylated and appears as 2 bands. cAMP (forskolin) acutely stimulated DRA activity in human colonoids and Caco-2 cells. In these cells, DRA is the predominant apical Cl DRA is acutely stimulated by cAMP by a process that is CFTR-dependent, but appears to be one of multiple regulatory effects of CFTR that does not require CFTR activity.

Sections du résumé

BACKGROUND & AIMS
SLC26A3 (DRA) is an electroneutral Cl
METHODS
This study re-evaluated cAMP regulation of DRA using new tools, including a successful knockout cell model, a specific DRA inhibitor (DRA
RESULTS
DRA is an apical protein in human proximal colon, differentiated colonoid monolayers, and Caco-2 cells. It is glycosylated and appears as 2 bands. cAMP (forskolin) acutely stimulated DRA activity in human colonoids and Caco-2 cells. In these cells, DRA is the predominant apical Cl
CONCLUSIONS
DRA is acutely stimulated by cAMP by a process that is CFTR-dependent, but appears to be one of multiple regulatory effects of CFTR that does not require CFTR activity.

Identifiants

pubmed: 30659943
pii: S2352-345X(19)30003-7
doi: 10.1016/j.jcmgh.2019.01.002
pmc: PMC6438990
pii:
doi:

Substances chimiques

Chloride-Bicarbonate Antiporters 0
SLC26A3 protein, human 0
SLC26A6 protein, human 0
Sulfate Transporters 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6
Colforsin 1F7A44V6OU
Cyclic AMP E0399OZS9N

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-653

Subventions

Organisme : NIDDK NIH HHS
ID : R24 DK099803
Pays : United States
Organisme : NIDDK NIH HHS
ID : P01 DK072084
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24 DK064388
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK061931
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK068271
Pays : United States
Organisme : NCATS NIH HHS
ID : U18 TR000552
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK116352
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK089502
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK061765
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK026523
Pays : United States

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Clin J Am Soc Nephrol. 2008 Nov;3(6):1861-8
pubmed: 18922984
J Clin Invest. 2007 Feb;117(2):428-37
pubmed: 17256057
Acta Physiol (Oxf). 2014 May;211(1):161-75
pubmed: 24373192
Gastroenterology. 2013 Dec;145(6):1358-1368.e1-4
pubmed: 24001788
Am J Physiol Cell Physiol. 2011 Feb;300(2):C276-86
pubmed: 21068358
Am J Physiol Cell Physiol. 2014 May 15;306(10):C943-60
pubmed: 24647542
Am J Physiol. 1984 May;246(5 Pt 1):G603-10
pubmed: 6426321
Gastroenterology. 2010 Aug;139(2):620-31
pubmed: 20398666
Am J Physiol Cell Physiol. 2010 May;298(5):C1057-65
pubmed: 20164375
Cell Mol Gastroenterol Hepatol. 2016 Jan 1;2(1):48-62.e3
pubmed: 26855967
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6249-53
pubmed: 1648734
Am J Physiol Cell Physiol. 2011 Apr;300(4):C771-82
pubmed: 21191106
Curr Opin Gastroenterol. 2012 Mar;28(2):130-4
pubmed: 22157512
Pflugers Arch. 2005 Feb;449(5):479-90
pubmed: 15480750
Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1140-9
pubmed: 15284023
Gastroenterology. 2009 Mar;136(3):893-901
pubmed: 19121635
JCI Insight. 2018 Jul 26;3(14):
pubmed: 30046015
Pflugers Arch. 1989 Sep;414(6):701-5
pubmed: 2554249
J Physiol. 2012 Nov 1;590(21):5317-34
pubmed: 22802588
Gastroenterology. 2016 Mar;150(3):638-649.e8
pubmed: 26677983
Physiol Rep. 2018 Mar;6(5):
pubmed: 29536650
Annu Rev Physiol. 2011;73:261-81
pubmed: 21054167
Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G202-10
pubmed: 19056765
Gastroenterology. 2008 Nov;135(5):1645-1653.e3
pubmed: 18930060
Gastroenterology. 2017 Nov;153(5):1338-1350.e3
pubmed: 28823863
Am J Physiol Cell Physiol. 2012 Mar 1;302(5):C781-95
pubmed: 22159084
Nat Cell Biol. 2004 Apr;6(4):343-50
pubmed: 15048129
Curr Top Membr. 2014;73:1-67
pubmed: 24745980
EMBO J. 2002 Nov 1;21(21):5662-72
pubmed: 12411484
Cell Mol Gastroenterol Hepatol. 2018 Feb 09;5(4):591-609
pubmed: 29930980
J Biol Chem. 2010 Oct 15;285(42):32227-32
pubmed: 20709758
Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1079-88
pubmed: 17170027
J Biol Chem. 2014 Feb 28;289(9):5449-61
pubmed: 24398676
Gastroenterology. 2002 Mar;122(3):709-24
pubmed: 11875004
Am J Physiol Gastrointest Liver Physiol. 2004 Jan;286(1):G102-9
pubmed: 12881227
Physiol Rep. 2014 Sep 28;2(9):
pubmed: 25263207
J Physiol. 2003 May 15;549(Pt 1):3-19
pubmed: 12651923

Auteurs

Chung-Ming Tse (CM)

Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Jianyi Yin (J)

Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Varsha Singh (V)

Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Rafiquel Sarker (R)

Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ruxian Lin (R)

Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Alan S Verkman (AS)

Department of Medicine, Department of Physiology, University of California San Francisco, San Francisco, California.

Jerrold R Turner (JR)

Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Mark Donowitz (M)

Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: mdonowit@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH